Pfeiffer, P. et al. 2017. S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies. Acta Oncologica. 56, 1 (Jan. 2017), 46–51. DOI:https://doi.org/10.1080/0284186X.2016.1257865.